The future of decentralized clinical trials in ophthalmologyByGeorge N. Magrath, MD, MBA, MS,Andrew D. Pucker, OD, PhD, FAAO,Winston Posvar, OD, MSDecember 31st 2023Research can drive opportunities for patients with rare diseases
Dry eye renaissance: Escalating cases meet with innovationByDavid Wirta, MD,George N. Magrath, MD, MBA, MSAugust 28th 2023For clinicians, the evolution of treatment is as much a responsibility as an opportunity.